Skip to content
PubMed This is a summary of 42 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 42 referenced papers

Top Authors

Norito Ishii
Kurume University
Enno Schmidt
University of Lübeck
Khalaf Kridin
Bar-Ilan University
Takashi Hashimoto
Osaka Metropolitan University
Hendri H. Pas
University Medical Center Groningen
Roberto Maglie
University of Florence
Marzia Caproni
Azienda Usl Toscana Centro
Kwesi Teye
Kurume University
Emiliano Antiga
University of Florence
Alberto Corrà
University of Florence

Top Institutions

Ranked by publications Top 10 institutions
04

Osaka Metropolitan University

Osaka, Japan

20 papers
05

Bar-Ilan University

Ramat Gan, Israel

19 papers
Contributors Khalaf Kridin
07

Azienda Usl Toscana Centro

Pistoia, Italy

8 papers
08

Temple University

Philadelphia, United States

3 papers
09

University of Utah

Salt Lake City, United States

3 papers

References

References (42)
  1. 1

    Immunobullous disease and ulcerative colitis: a case series of six patients.

    Sotiriou MC, Foo CW, Scholes CT, Zone JJ

    The British journal of dermatology 2015; (173(3)):792-6 doi:10.1111/bjd.13872.

    PMID: 25913891
  2. 2

    Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias.

    Willrich MA, Katzmann JA

    Clinical chemistry and laboratory medicine 2016; (54(6)):907-19.

    PMID: 26509779
  3. 3

    Clinical and immunological studies of 49 cases of various types of intercellular IgA dermatosis and 13 cases of classical subcorneal pustular dermatosis examined at Kurume University.

    Hashimoto T, Teye K, Ishii N

    The British journal of dermatology 2017; (176(1)):168-175 doi:10.1111/bjd.14780.

    PMID: 27258999
  4. 4

    A Clinicopathological Study of Pemphigus in Eastern India with Special Reference to Direct Immunofluorescence.

    Chowdhury J, Datta PK, Chowdhury SN, Das NK

    Indian journal of dermatology 2016; (61(3)):288-94 doi:10.4103/0019-5154.182422.

    PMID: 27293249
  5. 5

    Subcorneal Pustular Dermatosis: A Review of 30 Years of Progress.

    Watts PJ, Khachemoune A

    American journal of clinical dermatology 2016; (17(6)):653-671 doi:10.1007/s40257-016-0202-8.

    PMID: 27349653
  6. 6

    Complete remission of skin lesions in a patient with subcorneal pustular dermatosis (Sneddon-Wilkinson disease) treated with antimyeloma therapy: association with disappearance of M-protein.

    von dem Borne PA, Jonkman MF, van Doorn R

    The British journal of dermatology 2017; (176(5)):1341-1344 doi:10.1111/bjd.14954.

    PMID: 27516004
  7. 7

    IgA pemphigus showing IgA antibodies to desmoglein 1 and 3.

    Hegazy S, Bouchouicha S, Khaled A, et al.

    Dermatology practical & conceptual 2016; (6(4)):31-33 doi:10.5826/dpc.0604a07.

    PMID: 27867744
  8. 8

    Interruption of Sneddon-Wilkinson Subcorneal Pustulation with Infliximab.

    Kretschmer L, Maul JT, Hofer T, Navarini AA

    Case reports in dermatology 2017; (9(1)):140-144 doi:10.1159/000468917.

    PMID: 28559813
  9. 9

    Peptide mimetics of immunoglobulin A (IgA) and FcαRI block IgA-induced human neutrophil activation and migration.

    Heineke MH, van der Steen LPE, Korthouwer RM, et al.

    European journal of immunology 2017; (47(10)):1835-1845 doi:10.1002/eji.201646782.

    PMID: 28736835
  10. 10

    Systemic retinoids for treatment of recalcitrant IgA pemphigus.

    Schauer F, Kern JS, Kiritsi D

    Orphanet journal of rare diseases 2018; (13(1)):163 doi:10.1186/s13023-018-0899-y.

    PMID: 30227880
  11. 11

    Imatinib-induced IgA Pemphigus: Subcorneal Pustular Dermatosis Type.

    Sood A, Sinha P, Raman DK, Sinha A

    Indian dermatology online journal 2018; (9(5)):331-333 doi:10.4103/idoj.IDOJ_331_17.

    PMID: 30258803
  12. 12

    THE ONSET OF CLINICAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS.

    Nóbrega VG, Silva INN, Brito BS, et al.

    Arquivos de gastroenterologia 2018; (55(3)):290-295 doi:10.1590/S0004-2803.201800000-73.

    PMID: 30540094
  13. 13

    Chronic annular pustular psoriasis resembling subcorneal pustular dermatosis: A case report.

    Khosravi-Hafshejani T, Dutz JP

    SAGE open medical case reports 2019; (7()):2050313X19857392 doi:10.1177/2050313X19857392.

    PMID: 31258906
  14. 14

    Role of Fecal Calprotectin as a Noninvasive Indicator for Ulcerative Colitis Disease Activity.

    Nakov RV, Nakov VN, Gerova VA, Tankova LT

    Folia medica 2019; (61(2)):188-196.

    PMID: 31301663
  15. 15

    Oral Lesions in Autoimmune Bullous Diseases: An Overview of Clinical Characteristics and Diagnostic Algorithm.

    Rashid H, Lamberts A, Diercks GFH, et al.

    American journal of clinical dermatology 2019; (20(6)):847-861 doi:10.1007/s40257-019-00461-7.

    PMID: 31313078
  16. 16

    Pemphigus.

    Schmidt E, Kasperkiewicz M, Joly P

    Lancet (London, England) 2019; (394(10201)):882-894 doi:10.1016/S0140-6736(19)31778-7.

    PMID: 31498102
  17. 17

    IgA pemphigus: A systematic review.

    Kridin K, Patel PM, Jones VA, et al.

    Journal of the American Academy of Dermatology 2020; (82(6)):1386-1392 doi:10.1016/j.jaad.2019.11.059.

    PMID: 31812619
  18. 18

    A preliminary clinical trial comparing wet silver dressings versus wet-to-dry povidone-iodine dressings for wound healing in pemphigus vulgaris patients.

    Chen J, Zou Q, Hamblin MR, Wen X

    Dermatologic therapy 2021; (34(3)):e14906 doi:10.1111/dth.14906.

    PMID: 33611826
  19. 19

    A Case of Dapsone-induced Mild Methemoglobinemia with Dyspnea and Cyanosis.

    Hayama Y, Imanishi H, Yoshimoto N, et al.

    Acta dermatovenerologica Croatica : ADC 2020; (28(4)):249-250.

    PMID: 33835002
  20. 20

    Pathogenic Activation and Therapeutic Blockage of FcαR-Expressing Polymorphonuclear Leukocytes in IgA Pemphigus.

    Emtenani S, Ghorbanalipoor S, Mayer-Hain S, et al.

    The Journal of investigative dermatology 2021; (141(12)):2820-2828 doi:10.1016/j.jid.2021.06.007.

    PMID: 34246620
  21. 21

    The epidemiology of autoimmune bullous diseases in Sudan between 2000 and 2016.

    Siddig O, Mustafa MB, Kordofani Y, et al.

    PloS one 2021; (16(7)):e0254634 doi:10.1371/journal.pone.0254634.

    PMID: 34255799
  22. 22

    Comprehensive review on the pathophysiology, clinical variants and management of pemphigus (Review).

    Costan VV, Popa C, Hâncu MF, et al.

    Experimental and therapeutic medicine 2021; (22(5)):1335 doi:10.3892/etm.2021.10770.

    PMID: 34630689
  23. 23

    An Updated Review of Pemphigus Diseases.

    Malik AM, Tupchong S, Huang S, et al.

    Medicina (Kaunas, Lithuania) 2021; (57(10)) doi:10.3390/medicina57101080.

    PMID: 34684117
  24. 24

    Clinical, Histopathologic, and Immunohistochemical Features of Patients with IgG/IgA Pemphigus.

    Cho YT, Fu KT, Chen KL, et al.

    Biomedicines 2022; (10(5)) doi:10.3390/biomedicines10051197.

    PMID: 35625932
  25. 25

    Subcorneal pustular dermatosis-type IgA pemphigus associated with multiple myeloma: A case report and literature review.

    Koga H, Tsutsumi M, Teye K, et al.

    The Journal of dermatology 2023; (50(2)):234-238 doi:10.1111/1346-8138.16516.

    PMID: 35838241
  26. 26

    Clinical Patterns, Survival, Comorbidities, and Treatment Regimens in 149 Patients With Pemphigus in Tuscany (Italy): A 12-Year Hospital-Based Study.

    Quintarelli L, Coi A, Maglie R, et al.

    Frontiers in immunology 2022; (13()):895490 doi:10.3389/fimmu.2022.895490.

    PMID: 35880183
  27. 27

    Linear Immunoglobulin A (IgA) Bullous Dermatosis Mimicking Stevens-Johnson Syndrome.

    Park JS, Hamilton CD, Patel S, et al.

    Cureus 2022; (14(10)):e30309 doi:10.7759/cureus.30309.

    PMID: 36381872
  28. 28

    Significance of anti-desmocollin autoantibodies in pemphigus.

    Ishii N

    The Journal of dermatology 2023; (50(2)):132-139 doi:10.1111/1346-8138.16660.

    PMID: 36578135
  29. 29

    Profile of Cutaneous Bacterial Flora in Pemphigus Patients.

    Mohanty S, Saha S, Firdaus S, Sirka CS

    Journal of laboratory physicians 2023; (15(4)):616-620 doi:10.1055/s-0043-1768635.

    PMID: 37780880
  30. 30

    Clinical and immunopathological characteristics of autoimmune blistering skin diseases.

    Gunarić A, Šimić D, Marinović B

    Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2023; (32(4)):141-149.

    PMID: 38126096
  31. 31

    Superficial and Bullous Neutrophilic Dermatoses: Sneddon-Wilkinson, IgA Pemphigus, and Bullous Lupus.

    Manjaly P, Sanchez K, Gregoire S, et al.

    Dermatologic clinics 2024; (42(2)):307-315 doi:10.1016/j.det.2023.08.010.

    PMID: 38423689
  32. 32

    A case of IgA pemphigus with acantholysis in oral mucosal lesions.

    Yamanishi A, Ono N, Tsunoda A, et al.

    Skin health and disease 2024; (4(2)):e327 doi:10.1002/ski2.327.

    PMID: 38577061
  33. 33

    Diagnostic Utility of Direct Immunofluorescence on Paraffin-Embedded Skin Biopsy Samples for the Diagnosis of Autoimmune Vesiculobullous Lesions.

    Bk P, Panwar H, Joshi D, et al.

    Cureus 2024; (16(3)):e56916 doi:10.7759/cureus.56916.

    PMID: 38665766
  34. 34

    A case of IgA pemphigus, with a poor response to dapsone, successfully treated with adalimumab.

    Al-Zahawi S, Kamyab K, Balighi K

    Clinical case reports 2024; (12(5)):e8807 doi:10.1002/ccr3.8807.

    PMID: 38751960
  35. 35

    State-of-the-art diagnosis of autoimmune blistering diseases.

    van Beek N, Holtsche MM, Atefi I, et al.

    Frontiers in immunology 2024; (15()):1363032 doi:10.3389/fimmu.2024.1363032.

    PMID: 38903493
  36. 36

    Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance: A Review.

    Liu Y, Parks AL

    JAMA internal medicine 2025; (185(4)):450-456 doi:10.1001/jamainternmed.2024.8124.

    PMID: 39960681
  37. 37

    The application of direct immunofluorescence in the pathological diagnosis of oral mucosal diseases: Series of 116 cases.

    Xu Y, He X, Jie W, et al.

    Pathology, research and practice 2025; (270()):155989 doi:10.1016/j.prp.2025.155989.

    PMID: 40300523
  38. 38

    A 14-year multicentric follow-up study of atypical pemphigus variants in Italy: the VARIANT_P study.

    Quintarelli L, Bonanni I, Mariotti EB, et al.

    Clinical and experimental dermatology 2026; (51(2)):250-262 doi:10.1093/ced/llaf438.

    PMID: 41072932
  39. 39

    Recognizing Pemphigus Vulgaris in a Low Prevalence Setting: A Journey Through Multiple Diagnoses.

    Adedoja MEAV, Ramos Yason MMJ, Aquino-Villamin M

    Case reports in dermatological medicine 2026; (2026()):9778760 doi:10.1155/crdm/9778760.

    PMID: 42078003
  40. 40

    Case Report: A rare co-occurrence of IgA pemphigus and pyoderma gangrenosum associated with IgA-κ type monoclonal gammopathy of undetermined significance: a 19-year diagnostic and therapeutic journey.

    Xie Y, Liu X, Wu J, et al.

    Frontiers in immunology 2026; (17()):1832860 doi:10.3389/fimmu.2026.1832860.

    PMID: 42245644
  41. 41

    Clinical Indicators Suggesting Dapsone-Induced Methemoglobinemia in Dermatology Outpatients: A Pilot Retrospective Cohort Study.

    Mathews J, Thomas A, Lekshmi S P, et al.

    Cureus 2026; (18(6)):e111188 doi:10.7759/cureus.111188.

    PMID: 42333280
  42. 42

    Dapsone induced hemolysis and drop in saturation in normal glucose-6-phosphate dehydrogenase level patients - alarming presentation of poor man's drug: A series of 12 cases and review of literature.

    Pradhan S, Dash G

    Indian journal of pharmacology 2026; (58(4)):468-471 doi:10.4103/ijp.ijp_1323_25.

    PMID: 42583982